Annual report [Section 13 and 15(d), not S-K Item 405]

Significant Accounting Policies (Tables)

v3.25.1
Significant Accounting Policies (Tables)
 12 Months Ended
Dec. 31, 2024
Accounting Policies [Abstract]  
Schedule of Disaggregation of Revenue
The Company categorizes revenue based on various factors, such as the nature of contracts, as follows:
Revenue Type Year Ended December 31, 2024 % of Total Year Ended December 31, 2023 % of Total
(dollars in thousands)
Capitated revenue $ 1,483,602  98.9  % $ 1,252,309  98.9  %
Other patient service revenue:
Clinical fees & insurance revenue 5,934  0.4  5,192  0.3 
Care coordination / management fees 10,563  0.7  8,301  0.7 
Incentive fees 356  0.0  573  0.1 
Total other patient service revenue 16,853  1.1  14,066  1.1 
Total revenue $ 1,500,455  100.0  % $ 1,266,375  100.0  %
Long-Lived Assets Held-for-Sale
Assets Held for Sale
The Company classifies assets and related liabilities as held for sale when: (i) management has committed to a plan to sell the net assets, (ii) the net assets are available for immediate sale, (iii) there is an active program to locate a buyer, (iv) the sale and transfer of the net assets is probable within one year, (v) the net assets are being actively marketed for sale at price that is reasonable in relation to its current fair value, and (vi) it is unlikely that significant changes will be made to the plan to sell the net assets. Assets and liabilities held for sale are presented separately on our consolidated balance sheets at the lower of cost or fair value, less costs to sell. Depreciation and amortization expense for long-lived assets are not recorded while these assets are classified as held for sale. For each period that assets are classified as being held for sale, they are tested for recoverability.